Australia Harm Prevention Budget Proportions |
Great Britain new millennium expenditure on drug care and fight |
Europe Harm Reduction different positions |
||||||||
country |
decriminalization |
maintenance based treatment |
needle exchange |
pill testing |
user rooms |
controlled person distribution |
||||
research methods |
3% |
state benefits |
21.9% |
Belgium |
Yes |
Yes |
Yes |
Yes |
No |
Yes |
local council & community initiative |
3% |
health and education |
3.05% |
Germany |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
indigenous & ethnic minority |
4% |
courts & prisons |
17.19% |
France |
No |
Yes |
Yes |
Yes |
No |
No |
prisons |
7% |
police |
34.37% |
Greece |
No |
Yes |
Yes |
No |
No |
No |
epidemiology |
8% |
designed anti drugs fundings |
23.49% |
Italy |
Yes |
Yes |
Yes |
No |
No |
No |
consumer advocacy & human rights |
9% |
considered a failure as United Kingdom show highest rates of users in Europe and all prices low but herb cannabis has lowered while cannabis retail street price is (5$/gr in 2005), lowest in Europe |
Netherlands |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
|
law enforcement |
11% |
Austria |
Yes |
Yes |
Yes |
Yes |
No |
No |
||
harm reduction practice |
12% |
Portugal |
Yes |
Yes |
Yes |
No |
Yes |
Yes |
||
harm reduction theory & policy |
14% |
Spain |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
||
HIV/AIDS & hepatitis |
18% |
200 US$ / cap.year |
United Kingdom |
Yes |
Yes |
Yes |
Yes |
No |
Yes |
|
Sweden |
No |
Yes |
Yes |
No |
No |
No |
||||
Switzerland |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
||||